Unknown

Dataset Information

0

Synthesis and biological evaluation of novel urea- and guanidine-based derivatives for the treatment of obesity-related hepatic steatosis.

ABSTRACT: Leptin, the product of the obese gene, is an adipocyte-secreted protein hormone playing a key role in the progression of obesity and hepatic steatosis. In this study, 28 novel (thio)urea and guanidine-based analogues have been synthesized and N-(1-(4-(3-(2-chloroethyl)ureido)benzyl)piperidin-4-yl)-3-(trifluoromethyl) benzamide (7i) was found to be a potent regulator of leptin expression in 3T3-L1 adipocytes. Treatment with 7i at a dose of 50 mg/kg/day for 35 days reduced the body weight and liver weight of diet-induced obesity mice by 13.5% and 18.4%, respectively, while also improving the serum levels of triglyceride, total cholesterol, leptin, adiponectin, LDL-c, HDL-c. Hematoxylin-eosin (H&E) and Oil Red O staining also confirmed that 7i ameliorated fat deposition in liver tissue and restricted the size of adipocytes in obesity-related fatty liver disease.

SUBMITTER: Liang X 

PROVIDER: S-EPMC6271706 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Synthesis and biological evaluation of novel urea- and guanidine-based derivatives for the treatment of obesity-related hepatic steatosis.

Liang Xiaolin X   Pei Heying H   Ma Liang L   Ran Yan Y   Chen Jinying J   Wang Guangcheng G   Chen Lijuan L  

Molecules (Basel, Switzerland) 20140515 5

Leptin, the product of the obese gene, is an adipocyte-secreted protein hormone playing a key role in the progression of obesity and hepatic steatosis. In this study, 28 novel (thio)urea and guanidine-based analogues have been synthesized and N-(1-(4-(3-(2-chloroethyl)ureido)benzyl)piperidin-4-yl)-3-(trifluoromethyl) benzamide (7i) was found to be a potent regulator of leptin expression in 3T3-L1 adipocytes. Treatment with 7i at a dose of 50 mg/kg/day for 35 days reduced the body weight and live  ...[more]

Similar Datasets

Unknown Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors.
| S-EPMC7144934 | biostudies-literature
Unknown New Urea Derivatives as Potential Antimicrobial Agents: Synthesis, Biological Evaluation, and Molecular Docking Studies.
| S-EPMC6963781 | biostudies-literature
Unknown Design, synthesis, and biological evaluation of (thio)urea derivatives as potent <i>Escherichia coli β</i>-glucuronidase inhibitors.
| S-EPMC11328603 | biostudies-literature
Unknown Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis.
| S-EPMC1839890 | biostudies-literature
Unknown Synthesis, biological activities and docking studies of pleuromutilin derivatives with piperazinyl urea linkage.
| S-EPMC7993385 | biostudies-literature
Unknown Synthesis and Biological Evaluation of Novel Bufalin Derivatives.
| S-EPMC8999407 | biostudies-literature
Unknown Design, Synthesis, and Biological Evaluation of Axitinib Derivatives.
| S-EPMC6017704 | biostudies-literature
Unknown Synthesis and Evaluation of Anticancer Activities of Novel C-28 Guanidine-Functionalized Triterpene Acid Derivatives.
| S-EPMC6278366 | biostudies-literature
Unknown Design, Synthesis and Biological Evaluation of Arylpyridin-2-yl Guanidine Derivatives and Cyclic Mimetics as Novel MSK1 Inhibitors. An Application in an Asthma Model.
| S-EPMC7828447 | biostudies-literature
Unknown Synthesis and biological evaluation of (-)-kunstleramide and its derivatives.
| S-EPMC6071945 | biostudies-literature